ArticleJournal of nanobiotechnology2024

Ginseng-derived nanoparticles alleviate inflammatory bowel disease via the TLR4/MAPK and p62/Nrf2/Keap1 pathways.

Song Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.